Physical Activity and Fatigue in Early Multiple Sclerosis (MS)
NCT ID: NCT00882453
Last Updated: 2012-05-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1739 participants
OBSERVATIONAL
2006-08-31
2011-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Aerobic Exercise and Flu-like Symptoms Following Interferon Beta 1a Injections in Patients With Multiple Sclerosis?
NCT02236624
Noninterventional Study Assessing Cognitive Function and Physical Activity in People With Multiple Sclerosis
NCT01491100
Rehabilitation Study in MS Patients
NCT00780455
Effect of Aerobic Exercise on Side Effects of Disease Modifying Therapy With Subcutaneous Interferon-b1b in Patients With Multiple Sclerosis
NCT01122056
Physical Disability in Patients Treated With Betaferon
NCT00873340
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group 1
Interferon beta-1b (Betaseron, BAY86-5046)
Intravenous therapy according to product information
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Interferon beta-1b (Betaseron, BAY86-5046)
Intravenous therapy according to product information
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Clinically isolated Syndrome (CIS), under Interferon-beta-1b treatment
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Bayer
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Bayer Healthcare AG
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Bayer Study Director
Role: STUDY_DIRECTOR
Bayer
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Many Locations, , Australia
Many Locations, , Austria
Many Locations, , Bahrain
Many Locations, , Belgium
Many Locations, , Canada
Many Locations, , Colombia
Many Locations, , Czechia
Many Locations, , Denmark
Many Locations, , Egypt
Many Locations, , France
Many Locations, , Germany
Many Locations, , Greece
Many Locations, , Indonesia
Many Locations, , Israel
Many Locations, , Italy
Many Locations, , Jordan
Many Locations, , Kazakhstan
Many Locations, , Kuwait
Many Locations, , Lebanon
Many Locations, , Mexico
Many Locations, , Netherlands
Many Locations, , Norway
Many Locations, , Oman
Many Locations, , Portugal
Many Locations, , Slovenia
Many Locations, , South Korea
Many Locations, , Spain
Many Locations, , Sweden
Many Locations, , Switzerland
Many Locations, , Taiwan
Many Locations, , Thailand
Many Locations, , United Arab Emirates
Many Locations, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
BF0601
Identifier Type: OTHER
Identifier Source: secondary_id
310721
Identifier Type: OTHER
Identifier Source: secondary_id
13853
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.